Soluble AXL Is a Novel Blood Marker for Early Detection of Pancreatic Ductal Adenocarcinoma and Differential Diagnosis from Chronic Pancreatitis

0
7
Researchers explored the use of soluble AXL as a biomarker for pancreatic ductal adenocarcinoma. AXL was analysed by immunohistochemistry in human pancreatic tissue samples.
[Ebiomedicine]

Sorry, but the selected Zotpress account can't be found.

Full Article